Company · CIK 0001590560 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
uniQure N.V. · QURE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 SForm 4 → | Jul 7, 4:47 pm EDT | Matthew C KapustaCEO, Managing Director, Director | 21,082 | $45.16 | $952,051 | 519,227 | −3.90% | 10b5-1 |
| Jul 2, 2026 MForm 4 → | Jul 7, 4:47 pm EDT | Matthew C KapustaCEO, Managing Director, Director | 21,082 | $19.39 | $408,780 | 540,309 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:59 pm EDT | Walid Abi-SaabChief Medical Officer | 30,000 | $46.42 | $1,392,600 | 148,235 | −16.8% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:59 pm EDT | Walid Abi-SaabChief Medical Officer | 10,000 | $5.59 | $55,900 | 178,235 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:54 pm EDT | Jack KayeDirector | 21,167 | $46.44 | $983,030 | 25,996 | −44.9% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:54 pm EDT | Jack KayeDirector | 21,167 | $23.44 | $496,230 | 43,056 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 MForm 4 → | Jul 7, 4:47 pm EDT | Matthew C KapustaCEO, Managing Director, Director | 21,082 | — | — | 0 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:59 pm EDT | Walid Abi-SaabChief Medical Officer | 10,000 | — | — | 50,500 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:54 pm EDT | Jack KayeDirector | 21,167 | — | — | 0 | — | 10b5-1 |